GlassScriptPhysician profile
Alexander Schwed
NPI 1548518962
$5,538.84
in general payments reported to CMS, 2019-2025
14 companies · $3,666 in 2025
The $3,666 reported for 2025 was more than what 85% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.92 · 2020: $150 · 2022: $254 · 2023: $119 · 2024: $1,334 · 2025: $3,666.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $1,982 · Food and Beverage: $637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $1,981.50 |
| Food and Beverage | $637.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,552.95 | 2024-2025 | |
| Aroa Biosurgery Incorporated | $270.29 | 2023-2025 | |
| Integra Lifesciences Corporation | $175.13 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Medtronic, INC. | $161.80 | 2022 | |
| Acell, INC. | $150.03 | 2020 | |
| Vioptix INC | $41.26 | 2025 | T. Ox Tissue Oximeter |
| Solventum Corporation | $32.55 | 2025 | Prevena, Abthera Advance, V.A.C. Granufoam |
| Astrazeneca Pharmaceuticals LP | $29.41 | 2024 | Andexxa |
| Alexion Pharmaceuticals, INC. | $25.10 | 2022 | |
| Abbvie INC. | $24.04 | 2022 | |
| Teleflex LLC | $23.97 | 2022 | |
| Boston Scientific Corporation | $19.33 | 2022 | |
| Smith+Nephew, INC. | $17.06 | 2024 | Pico |
| Edwards Lifesciences Corporation | $15.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Schwed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.